Study Results
Results pending
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
Recruitment Status
COMPLETED
Clinical Phase
NA
Total Enrollment
240 participants
Study Classification
INTERVENTIONAL
Study Start Date
2009-01-31
Study Completion Date
2011-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
At the present time, scientific consensus exists on obesity multifactorial etiopatogenia. As well, professionals and researchers agree that the treatment must approach several scopes, such as dietetic, physical activity, pharmacologic and surgical. These two last ones should not be the first election and must be reserved for those cases of morbid obesities or in case the previous ones have failed. The combination of diet and exercise is still not sufficiently studied, in special, the addition of strength training, as we propose in this project, for which established intervention protocols do not exist, and that could suppose an additional benefit in the reduction of risk factors.
Therefore, the objectives that we aim in this project are enumerated below:
* To discover which are the most effective training protocols and to determine what type of exercise combined with nutrition is more appropriate for obesity intervention programs.
* To establish the relationship between markers related with cardiovascular risk (adopokines and lipid profile) and the different intervention protocols proposed.
* To describe the influence of nine genetic polymorphisms (selected by their relationship with the energy expense and the physical yield) on the effect of different training protocols.
* To determine how important is body composition (fat mass and muscle mass mainly) in total daily energy expenditure.
* To establish rules of nutritional and exercise intervention that can be applied in public and private training centers. If the proposed objectives are fulfilled, this would contribute to an improvement in patients health in long term, along with an enormous saving in public health. Therefore, the purpose of this project is to propose new lines of intervention in overweight and obese adults that, until now, little have been investigated. This way, resistance training is proposed in combination with cardiovascular training and endocrinologic treatment. It fits to emphasize that, as far as we know, it is the first project of these characteristics, that puts in touch the public and private sector (hospitals, universities and fitness area), to establish standardized relations protocols to allow a close pursuit of obese patients.
Therefore, the objectives that we aim in this project are enumerated below:
* To discover which are the most effective training protocols and to determine what type of exercise combined with nutrition is more appropriate for obesity intervention programs.
* To establish the relationship between markers related with cardiovascular risk (adopokines and lipid profile) and the different intervention protocols proposed.
* To describe the influence of nine genetic polymorphisms (selected by their relationship with the energy expense and the physical yield) on the effect of different training protocols.
* To determine how important is body composition (fat mass and muscle mass mainly) in total daily energy expenditure.
* To establish rules of nutritional and exercise intervention that can be applied in public and private training centers. If the proposed objectives are fulfilled, this would contribute to an improvement in patients health in long term, along with an enormous saving in public health. Therefore, the purpose of this project is to propose new lines of intervention in overweight and obese adults that, until now, little have been investigated. This way, resistance training is proposed in combination with cardiovascular training and endocrinologic treatment. It fits to emphasize that, as far as we know, it is the first project of these characteristics, that puts in touch the public and private sector (hospitals, universities and fitness area), to establish standardized relations protocols to allow a close pursuit of obese patients.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
A Nutritional Intervention and Physical Activity Program Reduce Body Weight in Women Newly Diagnosed With Breast Cancer.
NCT04980118
Breast Cancer
Body Weight Changes
Weight Loss
+1 more
COMPLETED
NA
Multidisciplinary Intervention With Cognitive Remediation Therapy for Obese Adults
NCT05295745
Obesity
UNKNOWN
NA
Program for the Comprehensive Neurocognitive Treatment of Excess Weight
NCT05158075
Obesity
Overweight
COMPLETED
NA
Interdisciplinary Intervention in Patients With Obesity and Other Metabolic Diseases
NCT02573688
Obesity
COMPLETED
NA
Energy Expenditure and Weight Loss Maintenance
NCT03422380
Obesity
Weight Change, Body
Weight Loss
+1 more
COMPLETED
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Obesity
Overweight
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
Allocation Method
RANDOMIZED
Intervention Model
PARALLEL
Two phases, the first for overweight, and the second for obese people
Primary Study Purpose
PREVENTION
Blinding Strategy
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Nutrition
This groups will follow a diet.
Group Type
EXPERIMENTAL
Exercise
Intervention Type
OTHER
Different groups will carry out different exercise protocols during 16 weeks under the same nutritional intervention.
Nutrition + resistance training
In this group, nutrition and resistance training will be combined.
Group Type
EXPERIMENTAL
Exercise
Intervention Type
OTHER
Different groups will carry out different exercise protocols during 16 weeks under the same nutritional intervention.
Nutrition + aerobic training
In this group nutrition and aerobic training will be combined.
Group Type
EXPERIMENTAL
Exercise
Intervention Type
OTHER
Different groups will carry out different exercise protocols during 16 weeks under the same nutritional intervention.
Nutrition + mixed training
In this group the nutrition will be combined with 50% of resistance training plus 50% of aerobic training.
Group Type
EXPERIMENTAL
Exercise
Intervention Type
OTHER
Different groups will carry out different exercise protocols during 16 weeks under the same nutritional intervention.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Exercise
Different groups will carry out different exercise protocols during 16 weeks under the same nutritional intervention.
Intervention Type
OTHER
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Volunteers: men and women from Comunidad de Madrid (Zone 5 of Health System) who sign the informed consent.
* Ages 18 - 50 years old.
* Pre-menopausal.
* Body mass index (BMI) of 25 - 30 kg•m-2 (both included).
* Able to attend exercise classes 3 times per week (Monday, Wednesday and Friday). No plans for excessive travel. No plans to move from area for study period (January 2010 - June 2010, both included).
* Able to follow the nutritional treatment (avoid medication or substances known to interfere with body weight regulation, including anti-depressive medication, diuretics, etc., 15 days before study starts).
* Willing to not participate in other formal or informal weight loss program during the period of the study.
* Sedentary (less than once a week of training or two hours of physical activity class).
* Volunteers: men and women from Comunidad de Madrid (Zone 5 of Health System) who sign the informed consent.
* Ages 18 - 50 years old.
* Pre-menopausal.
* Body mass index (BMI) of 30 - 35 kg•m-2 (both included).
* Able to attend exercise classes 3 times per week (Monday, Wednesday and Friday). No plans for excessive travel. No plans to move from area for study period (January 2011 - June 2011, both included).
* Able to follow the nutritional treatment (avoid medication or substances known to interfere with body weight regulation, including anti-depressive medication, diuretics, etc., 15 days before study starts).
* Willing to not participate in other formal or informal weight loss program during the period of the study.
* Sedentary (less than once a week of training or two hours of physical activity class).
* Ages 18 - 50 years old.
* Pre-menopausal.
* Body mass index (BMI) of 25 - 30 kg•m-2 (both included).
* Able to attend exercise classes 3 times per week (Monday, Wednesday and Friday). No plans for excessive travel. No plans to move from area for study period (January 2010 - June 2010, both included).
* Able to follow the nutritional treatment (avoid medication or substances known to interfere with body weight regulation, including anti-depressive medication, diuretics, etc., 15 days before study starts).
* Willing to not participate in other formal or informal weight loss program during the period of the study.
* Sedentary (less than once a week of training or two hours of physical activity class).
* Volunteers: men and women from Comunidad de Madrid (Zone 5 of Health System) who sign the informed consent.
* Ages 18 - 50 years old.
* Pre-menopausal.
* Body mass index (BMI) of 30 - 35 kg•m-2 (both included).
* Able to attend exercise classes 3 times per week (Monday, Wednesday and Friday). No plans for excessive travel. No plans to move from area for study period (January 2011 - June 2011, both included).
* Able to follow the nutritional treatment (avoid medication or substances known to interfere with body weight regulation, including anti-depressive medication, diuretics, etc., 15 days before study starts).
* Willing to not participate in other formal or informal weight loss program during the period of the study.
* Sedentary (less than once a week of training or two hours of physical activity class).
Exclusion Criteria
* Smoking within six months, or use of tobacco or nicotine product.
* Women with irregular menstrual cycle (except with hormone therapy).
* Following a weight loss diet, vegetarians or food restriction due to religion.
* Self-reported weight loss or gain \>5% in past 6 months.
* Are not pregnant, or haven´t been in the past six months. Are not currently nursing or planning to become pregnant during the study period (year 2010).
* Need a special diet by associated disease (celiac disease or chronic renal insufficiency).
* Have metabolic syndrome or fulfill three or more of the following criteria: abdominal obesity (waist diameter \> 102 cm in men and \> 88 cm in women), blood pressure ≥ 130/85 mm Hg, basal glycemia ≥ 110 mg/dL, triglyceride level \> 150 mg/dL and C-HDL \< 40 mg/dL in women and \< 50 mg/dL in men.
* Diabetes.
* Anemia (Hct \< 37%).
* Uncontrolled high blood pressure (Systolic \> 160 mm Hg or diastolic \> 100 mm Hg in rest). Current use of more than one anti-hypertensive medication.
* Substance abuse (drugs, alcohol…). High or moderate consumes of alcohol. More than 2 glasses to the day of any alcoholic substance. Current use of diuretics, beta blockers, steroids or blood thinners.
* Contraindication to exercise. Alterations, syndromes or diseases detected by electrocardiogram (EKG) o echocardiography. Have injuries o pathologies of the locomotive apparatus that prevent the correct execution of the exercises of the program. Any illness that would prevent participation in a moderate-intense exercise program.
* Have had cancer in the past 5 years, except skin cancer.
* Coronary artery disease, liver disease, pulmonary disease, renal disease or other systemic disorders.
* History or evidence of cardiovascular disease, alterations, syndromes or other mayor chronic illness. Have history of heart disease, heart attacks or heart surgery.
* Have any illness known to interfere with body weight loss: clinical depression, eating disorder (anorexia, bulimia, etc.), psychological diseases (schizophrenia, etc.), dementia or cognitive function decreased, hypothyroidism no controlled or history of genetic or chromosomal disorder.
* Have had bariatric surgery or stomach bypass surgery.
* Gross physical impairment.
* Blindness or retinopathy.
For Obese phase:
* Smoking within six months, or use of tobacco or nicotine product.
* Women with irregular menstrual cycle (except with hormone therapy).
* Following a weight loss diet, vegetarians or food restriction due to religion.
* Self-reported weight loss or gain \>5% in past 6 months.
* Are not pregnant, or haven´t been in the past six months. Are not currently nursing or planning to become pregnant during the study period (year 2011).
* Need a special diet by associated disease (celiac disease or chronic renal insufficiency).
* Have metabolic syndrome or fulfill three or more of the following criteria: abdominal obesity (waist diameter \> 102 cm in men and \> 88 cm in women), blood pressure ≥ 130/85 mm Hg, basal glycemia ≥ 110 mg/dL, triglyceride level \> 150 mg/dL and C-HDL \< 40 mg/dL in women and \< 50 mg/dL in men.
* Diabetes.
* Anemia (Hct \< 37%).
* Uncontrolled high blood pressure (Systolic \> 160 mm Hg or diastolic \> 100 mm Hg in rest). Current use of more than one anti-hypertensive medication.
* Substance abuse (drugs, alcohol…). High or moderate consumes of alcohol. More than 2 glasses to the day of any alcoholic substance. Current use of diuretics, beta blockers, steroids or blood thinners.
* Contraindication to exercise. Alterations, syndromes or diseases detected by electrocardiogram (EKG) o echocardiography. Have injuries o pathologies of the locomotive apparatus that prevent the correct execution of the exercises of the program. Any illness that would prevent participation in a moderate-intense exercise program.
* Have had cancer in the past 5 years, except skin cancer.
* Coronary artery disease, liver disease, pulmonary disease, renal disease or other systemic disorders.
* History or evidence of cardiovascular disease, alterations, syndromes or other mayor chronic illness. Have history of heart disease, heart attacks or heart surgery.
* Have any illness known to interfere with body weight loss: clinical depression, eating disorder (anorexia, bulimia, etc.), psychological diseases (schizophrenia, etc.), dementia or cognitive function decreased, hypothyroidism no controlled or history of genetic or chromosomal disorder.
* Have had bariatric surgery or stomach bypass surgery.
* Gross physical impairment.
* Blindness or retinopathy.
* Women with irregular menstrual cycle (except with hormone therapy).
* Following a weight loss diet, vegetarians or food restriction due to religion.
* Self-reported weight loss or gain \>5% in past 6 months.
* Are not pregnant, or haven´t been in the past six months. Are not currently nursing or planning to become pregnant during the study period (year 2010).
* Need a special diet by associated disease (celiac disease or chronic renal insufficiency).
* Have metabolic syndrome or fulfill three or more of the following criteria: abdominal obesity (waist diameter \> 102 cm in men and \> 88 cm in women), blood pressure ≥ 130/85 mm Hg, basal glycemia ≥ 110 mg/dL, triglyceride level \> 150 mg/dL and C-HDL \< 40 mg/dL in women and \< 50 mg/dL in men.
* Diabetes.
* Anemia (Hct \< 37%).
* Uncontrolled high blood pressure (Systolic \> 160 mm Hg or diastolic \> 100 mm Hg in rest). Current use of more than one anti-hypertensive medication.
* Substance abuse (drugs, alcohol…). High or moderate consumes of alcohol. More than 2 glasses to the day of any alcoholic substance. Current use of diuretics, beta blockers, steroids or blood thinners.
* Contraindication to exercise. Alterations, syndromes or diseases detected by electrocardiogram (EKG) o echocardiography. Have injuries o pathologies of the locomotive apparatus that prevent the correct execution of the exercises of the program. Any illness that would prevent participation in a moderate-intense exercise program.
* Have had cancer in the past 5 years, except skin cancer.
* Coronary artery disease, liver disease, pulmonary disease, renal disease or other systemic disorders.
* History or evidence of cardiovascular disease, alterations, syndromes or other mayor chronic illness. Have history of heart disease, heart attacks or heart surgery.
* Have any illness known to interfere with body weight loss: clinical depression, eating disorder (anorexia, bulimia, etc.), psychological diseases (schizophrenia, etc.), dementia or cognitive function decreased, hypothyroidism no controlled or history of genetic or chromosomal disorder.
* Have had bariatric surgery or stomach bypass surgery.
* Gross physical impairment.
* Blindness or retinopathy.
For Obese phase:
* Smoking within six months, or use of tobacco or nicotine product.
* Women with irregular menstrual cycle (except with hormone therapy).
* Following a weight loss diet, vegetarians or food restriction due to religion.
* Self-reported weight loss or gain \>5% in past 6 months.
* Are not pregnant, or haven´t been in the past six months. Are not currently nursing or planning to become pregnant during the study period (year 2011).
* Need a special diet by associated disease (celiac disease or chronic renal insufficiency).
* Have metabolic syndrome or fulfill three or more of the following criteria: abdominal obesity (waist diameter \> 102 cm in men and \> 88 cm in women), blood pressure ≥ 130/85 mm Hg, basal glycemia ≥ 110 mg/dL, triglyceride level \> 150 mg/dL and C-HDL \< 40 mg/dL in women and \< 50 mg/dL in men.
* Diabetes.
* Anemia (Hct \< 37%).
* Uncontrolled high blood pressure (Systolic \> 160 mm Hg or diastolic \> 100 mm Hg in rest). Current use of more than one anti-hypertensive medication.
* Substance abuse (drugs, alcohol…). High or moderate consumes of alcohol. More than 2 glasses to the day of any alcoholic substance. Current use of diuretics, beta blockers, steroids or blood thinners.
* Contraindication to exercise. Alterations, syndromes or diseases detected by electrocardiogram (EKG) o echocardiography. Have injuries o pathologies of the locomotive apparatus that prevent the correct execution of the exercises of the program. Any illness that would prevent participation in a moderate-intense exercise program.
* Have had cancer in the past 5 years, except skin cancer.
* Coronary artery disease, liver disease, pulmonary disease, renal disease or other systemic disorders.
* History or evidence of cardiovascular disease, alterations, syndromes or other mayor chronic illness. Have history of heart disease, heart attacks or heart surgery.
* Have any illness known to interfere with body weight loss: clinical depression, eating disorder (anorexia, bulimia, etc.), psychological diseases (schizophrenia, etc.), dementia or cognitive function decreased, hypothyroidism no controlled or history of genetic or chromosomal disorder.
* Have had bariatric surgery or stomach bypass surgery.
* Gross physical impairment.
* Blindness or retinopathy.
Minimum Eligible Age
18 Years
Maximum Eligible Age
50 Years
Eligible Sex
ALL
Accepts Healthy Volunteers
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Universidad Complutense de Madrid
OTHER
Sponsor Role
collaborator
Hospital Universitario La Paz
OTHER
Sponsor Role
collaborator
Hospital Universitario Marqués de Valdecilla
OTHER
Sponsor Role
collaborator
Universidad Politecnica de Madrid
OTHER
Sponsor Role
lead
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Pedro JoseBenito Peinado
PhD
Responsibility Role
PRINCIPAL_INVESTIGATOR
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Pedro J Benito, PhD
Role: PRINCIPAL_INVESTIGATOR
Department of Health and Human Performance, Universidad Politécnica de Madrid
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Pedro J. Benito Peinado
Madrid, , Spain
Site Status
Facultad de Ciencias de la Actividad Física y del Deporte
Madrid, , Spain
Site Status
Countries
Review the countries where the study has at least one active or historical site.
Spain
References
Explore related publications, articles, or registry entries linked to this study.
Cupeiro R, Benito P, Amigo T, Gonzalez-Lamuno D. The association of SLC16A1 (MCT1) gene polymorphism with body composition changes during weight loss interventions: A randomized trial with sex-dependent analysis. Appl Physiol Nutr Metab. 2025 Jan 1;50:1-12. doi: 10.1139/apnm-2024-0246.
Reference Type
DERIVED
Benito PJ, Lopez-Plaza B, Bermejo LM, Peinado AB, Cupeiro R, Butragueno J, Rojo-Tirado MA, Gonzalez-Lamuno D, Gomez-Candela C, On Behalf Of The Pronaf Study Group. Strength plus Endurance Training and Individualized Diet Reduce Fat Mass in Overweight Subjects: A Randomized Clinical Trial. Int J Environ Res Public Health. 2020 Apr 10;17(7):2596. doi: 10.3390/ijerph17072596.
Reference Type
DERIVED
Benito PJ, Cupeiro R, Peinado AB, Rojo MA, Maffulli N; PRONAF Study Group. Influence of previous body mass index and sex on regional fat changes in a weight loss intervention. Phys Sportsmed. 2017 Nov;45(4):450-457. doi: 10.1080/00913847.2017.1380500. Epub 2017 Oct 5.
Reference Type
DERIVED
Castro EA, Judice PB, Silva AM, Teixeira PJ, Benito PJ. Sedentary behavior and compensatory mechanisms in response to different doses of exercise-a randomized controlled trial in overweight and obese adults. Eur J Clin Nutr. 2017 Dec;71(12):1393-1398. doi: 10.1038/ejcn.2017.84. Epub 2017 May 31.
Reference Type
DERIVED
Benito PJ, Alvarez-Sanchez M, Diaz V, Morencos E, Peinado AB, Cupeiro R, Maffulli N; PRONAF Study Group. Cardiovascular Fitness and Energy Expenditure Response during a Combined Aerobic and Circuit Weight Training Protocol. PLoS One. 2016 Nov 10;11(11):e0164349. doi: 10.1371/journal.pone.0164349. eCollection 2016.
Reference Type
DERIVED
Benito PJ, Bermejo LM, Peinado AB, Lopez-Plaza B, Cupeiro R, Szendrei B, Calderon FJ, Castro EA, Gomez-Candela C; PRONAF Study Group. Change in weight and body composition in obese subjects following a hypocaloric diet plus different training programs or physical activity recommendations. J Appl Physiol (1985). 2015 Apr 15;118(8):1006-13. doi: 10.1152/japplphysiol.00928.2014. Epub 2015 Feb 26.
Reference Type
DERIVED
Rojo-Tirado MA, Benito PJ, Atienza D, Rincon E, Calderon FJ. Effects of age, sex, and treatment on weight-loss dynamics in overweight people. Appl Physiol Nutr Metab. 2013 Sep;38(9):967-76. doi: 10.1139/apnm-2012-0441. Epub 2013 Apr 30.
Reference Type
DERIVED
Morencos E, Romero B, Peinado AB, Gonzalez-Gross M, Fernandez C, Gomez-Candela C, Benito PJ; PRONAF study group. Effects of dietary restriction combined with different exercise programs or physical activity recommendations on blood lipids in overweight adults. Nutr Hosp. 2012 Nov-Dec;27(6):1916-27. doi: 10.3305/nh.2012.27.6.6057.
Reference Type
DERIVED
Zapico AG, Benito PJ, Gonzalez-Gross M, Peinado AB, Morencos E, Romero B, Rojo-Tirado MA, Cupeiro R, Szendrei B, Butragueno J, Bermejo M, Alvarez-Sanchez M, Garcia-Fuentes M, Gomez-Candela C, Bermejo LM, Fernandez-Fernandez C, Calderon FJ. Nutrition and physical activity programs for obesity treatment (PRONAF study): methodological approach of the project. BMC Public Health. 2012 Dec 21;12:1100. doi: 10.1186/1471-2458-12-1100.
Reference Type
DERIVED
Loria-Kohen V, Fernandez-Fernandez C, Bermejo LM, Morencos E, Romero-Moraleda B, Gomez-Candela C. Effect of different exercise modalities plus a hypocaloric diet on inflammation markers in overweight patients: a randomised trial. Clin Nutr. 2013 Aug;32(4):511-8. doi: 10.1016/j.clnu.2012.10.015. Epub 2012 Nov 6.
Reference Type
DERIVED
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
PRONAF
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.
Effect of a Protein Intake on Weight Loss of Overweight/Obese Adults
NCT05368311
COMPLETED
NA
PACIFIC: Providing Adults Collaborative Interventions For Ideal Changes
NCT02516839
COMPLETED
NA
Innovative Approaches to Diet, Exercise and Activity
NCT01131871
COMPLETED
PHASE2
Lifestyle Intervention on Patients With Overweight or Obesity
NCT06829862
COMPLETED
NA
Long-term Effects of Lifestyle Intervention in Obesity and Genetic Influence
NCT01067157
COMPLETED
NA
"Program "Cerdanya on Fitness" to Improve the Lifestyle of People With Obesity in Cerdanya (CF).
NCT05420116
COMPLETED
NA
Weight Loss and Exercise in Obese, Physically Limited, Older Women and Men
NCT00146107
COMPLETED
PHASE3
Study to Promote Physical Activity Among Overweight Persons
NCT00313040
COMPLETED
PHASE1/PHASE2
Effects of Physical Training and Nutrition Education on Adipocytokines in Severely Obese Teenagers
NCT01188642
COMPLETED
Health and Wellness in Obesity
NCT02102061
UNKNOWN
NA
A Multidisciplinary Intervention for Weight Loss
NCT04622982
COMPLETED
NA
A Toolbox Approach to Obesity Treatment in Primary Care
NCT01922934
COMPLETED
PHASE4
Promotion of Exercise and Health in Obesity
NCT00513084
UNKNOWN
NA
Lifestyle On-line Intervention in Patients With Obesity and Hypertension
NCT03396302
COMPLETED
NA
Anthropometric Parameters, Metabolic Profile and Function of the Respiratory System in Obese Patients
NCT03346421
UNKNOWN
Pragmatic Weight Loss Intervention During Menopause
NCT04487782
COMPLETED
Prevention & Promotion in the Treatment of Obesity
NCT02990494
COMPLETED
NA
Lifestyle Intervention in Morbidly Obese Patients
NCT00464984
COMPLETED
NA
Rapid Evaluation of Innovative Intervention Components to Maximize the Health Benefits of Behavioral Obesity Treatment Delivered Online: An Application of Multiphase Optimization Strategy
NCT04520256
COMPLETED
PHASE2/PHASE3
Psychophysical Analysis of Adolescent Patients With Obesity and Efficacy of the Respiratory Approach (PSICOFISADOLOB).
NCT06296407
COMPLETED
NA
E-support for Healthcare Processes - WEIGHT LOSS
NCT01716325
UNKNOWN
NA
Weight Management Skills in African American Outpatients
NCT00146081
COMPLETED
NA
Nutritional Restriction and Activity Thermogenesis
NCT00065338
COMPLETED
PHASE1
Promoting Weight Loss and Psychological Well-being in Obese Patients
NCT03962205
COMPLETED
NA
The Effect of Lifestyle Treatment in Patients With Morbid Obesity
NCT03593148
RECRUITING
NA